Bausch Health Companies I... (BHC)
NYSE: BHC
· Real-Time Price · USD
4.53
-0.08 (-1.74%)
At close: May 30, 2025, 3:59 PM
4.53
0.06%
After-hours: May 30, 2025, 05:16 PM EDT
-1.74% (1D)
| Bid | 4.45 |
| Market Cap | 1.67B |
| Revenue (ttm) | 9.6B |
| Net Income (ttm) | -42.62M |
| EPS (ttm) | -0.12 |
| PE Ratio (ttm) | -37.71 |
| Forward PE | 1.04 |
| Analyst | Hold |
| Ask | 4.65 |
| Volume | 787,292 |
| Avg. Volume (20D) | 2,070,288 |
| Open | 4.50 |
| Previous Close | 4.61 |
| Day's Range | 4.45 - 4.55 |
| 52-Week Range | 3.96 - 9.85 |
| Beta | 0.34 |
Analyst Forecast
According to 0 analyst ratings, the average rating for BHC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+9.96%
Bausch Health shares are trading higher after anno...
Unlock content with
Pro Subscription
3 months ago
+10.29%
Bausch Health shares are trading higher after the company reported better-than-expected Q4 sales.
2 weeks ago · accessnewswire.com
Bausch Health Announces 2025 Annual Meeting of Shareholder ResultsLAVAL, QC / ACCESS Newswire / May 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the election of the 10 directors nominated at its 2025 annual meeting of shareholders ("An...
1 month ago · seekingalpha.com
Bausch Health Companies Inc. (BHC) Q1 2025 Earnings Call TranscriptBausch Health Companies Inc. (NYSE:BHC ) Q1 2025 Earnings Conference Call April 30, 2025 5:00 PM ET Company Participants Garen Sarafian - IR Thomas Appio - CEO Jean-Jacques Charhon - EVP & CFO Confere...